Cardio-protective effect of dapagliflozin against doxorubicin induced cardiomyopathy in rats.

Abstract

This study revealed, for the first time, that dapagliflozin can improve DOX-induced cardiac dysfunction and pathological changes in non-diabetic rats. This result has shown that dapaglifozin, may be promising in terms of preventing cardiac damage that may develop in cancer treatment.